NON-VESTIBULAR SCHWANNOMA

Clinical trials for NON-VESTIBULAR SCHWANNOMA explained in plain language.

Never miss a new study

Get alerted when new NON-VESTIBULAR SCHWANNOMA trials appear

Sign up with your email to follow new studies for NON-VESTIBULAR SCHWANNOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for controlling rare genetic tumors

Disease control Ongoing

This study is testing two repurposed cancer drugs, brigatinib and neratinib, to see if they can slow or stop the growth of tumors in people with NF2-related schwannomatosis. It will enroll about 100 participants aged 12 and older who have specific, growing tumors. The trial uses …

Matched conditions: NON-VESTIBULAR SCHWANNOMA

Phase: PHASE2 • Sponsor: Scott R. Plotkin, MD, PhD • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

NON-VESTIBULAR SCHWANNOMA

Get alerted when new NON-VESTIBULAR SCHWANNOMA trials appear

New hope for controlling rare genetic tumors